
Chemical and Pharmaceutical Bulletin p. 501 - 510 (1999)
Update date:2022-08-03
Topics:
Ohkawa, Takehiko
Zenkoh, Tatsuya
Tomita, Masayuki
Hosogai, Naomi
Hemmi, Keiji
Tanaka, Hirokazu
Setoi, Hiroyuki
The present study was undertaken to evaluate whether a novel series of 2,6-diaza-5-oxobicyclo[5.4.0]undeca-1(7),8,10-triene derivatives exhibited antagonistic activity for vasopressin V1 and V2 receptors. Most of these compounds were
View MoreXi'an Kaixiang Photoelectric Technology Co., Ltd
website:http://www.kxmaterials.com/
Contact:86-29-15991651477
Address:Building 6, Biopharmaceutical Industry R&D Cluster Base, No. 16, Caotang 4th Road, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province, China
Contact:+86-511-88790000
Address:338 North Yushan Rd, Zhenjiang, Jiangsu 212016
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Doi:10.1016/0957-4166(95)00135-C
(1995)Doi:10.1021/ja01637a047
(1954)Doi:10.1021/ic00126a016
()Doi:10.1016/j.tetlet.2005.11.003
(2006)Doi:10.1246/cl.1995.459
(1995)Doi:10.1021/jo00120a036
(1995)